Documents to download

The NHS Funding Bill is a two-clause government bill intended to place a legal duty on the Government to guarantee a minimum level of revenue spending for the NHS in England in each year from 2020/21 to 2023/24 inclusive. The amounts specified rise from £127.0 billion in 2020/21 to £148.5 billion in 2023/24. These figures compare with £120.1 billion in 2019/20.

The bill would place into law a funding settlement for NHS England first announced by the then Prime Minister, Theresa May, in June 2018. This formed the basis of the NHS’s Long Term Plan, published in January 2019. Legislation to enshrine the settlement in law was a commitment in both the Conservative Party 2019 general election manifesto and the Queen’s Speech in December 2019.

The bill passed through its House of Commons stages unamended. Issues debated included:

  • The funding amounts in the bill being set out in cash terms, not real terms (ie adjusted for inflation) meaning that if inflation exceeds expectations, the purchasing power of the settlement might be less than anticipated.
  • That the bill only relates to revenue spending. Some speakers argued that other areas should also be covered, such as: capital spending; education and training; the local authority public health grant; and social care.
  • The relationship between the bill and the aim of achieving “parity of esteem” for mental health services.
  • The effect of the funding settlement on the NHS’s ability to meet its performance targets.

The bill is a ‘money bill’. This means it can receive royal assent without being passed by the House of Lords, and also that the House of Commons is not obliged to consider any amendments made by the Lords. It is normal practice for such bills not to be committed to a committee stage in the Lords, instead going directly from second to third readings.

The bill is an example of the Government committing in primary legislation to an action which is already within its power.


Documents to download

Related posts

  • The Government has announced that the England-wide Covid-19 restrictions commonly referred to as ‘lockdown 2’ will not be renewed past 2 December 2020. The restrictions are to be replaced with a revised tier structure for England similar to the one in place before the second lockdown. The revised tiers form part of the Government’s Winter Plan, which was announced on 23 November 2020.

  • The Chancellor of the Exchequer, Rishi Sunak, delivered a spending review statement on 25 November 2020. The Government said the review’s priorities were “to support the Government’s response to Covid-19, invest in the UK’s recovery and deliver on promises to the British people”. Alongside the spending review, the Office for Budget Responsibility set out its latest forecasts for the economy and for the public finances.

  • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.